Morgan Stanley set a $26.00 price target on Lakefront Biotherapeutics American Depositary Shares in a research note on Tuesday. Get Lakefront Biotherapeutics American Depositary Shares alerts:Get Our Latest Research Report on Lakefront Biotherapeutics American Depositary SharesLakefront Biotherapeutics American Depositary Shares Trading Up 3.9%NASDAQ LKFT traded up $1.05 during trading hours on Tuesday, reaching $27.96. Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT – Get Free Report) last released its quarterly earnings results on Monday, August 10th. Arax Advisory Partners raised its holdings in shares of Lakefront Biotherapeutics American Depositary Shares by 319.2% in the 4th quarter. Further ReadingReceive News & Ratings for Lakefront Biotherapeutics American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakefront Biotherapeutics American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.